Regardless of CLR treatment, CFA+GLA-SE/CDG immunization significantly elicited Mav CFA-specific CD4+CD44+CD62 L− T cells producing IFN-γ+IL-17A+, and IFN-γ+TNF-α+ but not IFN-γ+IL-2+ in the lungs in the CFA+GLA-SE/CDG-immunized group compared with those in the infection control group (Figure 7a,b). The gene discussed is CD44; the disease is infection.